Western governments and agencies must share their resources with local scientists conducting HIV research in such developing countries as Uganda say researchers from Imperial College London (medicalnewstoday.com, 10/23).
In a commentary published today in the journal Nature Immunology, researchers argue that more cutting-edge laboratories are needed to conduct HIV-vaccine trials and develop treatment in impoverished nations.
“Old fashioned ‘parachute science’—where scientists from the developed world flew in, bled a few patients and immediately returned to their country of origin with their samples—are no longer required or acceptable,” says Professor Frances Gotch, one of the authors of the commentary. “In-house development and research is an effective and efficient way forward.”
Beth Benne, RN, is HIV negative, but
the virus has impacted her life. She currently supervises a biannual HIV/AIDS awareness week as
the director of the student health center at Pierce College, a
community commuter school in Woodland Hills, California.
Woman of the Month is supported by exclusive advertising from Gilead.
Overheard in the Women's Forum
"I recently met a guy who is negative. I did tell him about my status and he decided to kiss me anyway (we didn't go further than that). But a day later, he called and said that he actually had a mouth ulcer that time when we kissed and he was very worried. Asked if he can get the virus from me that way. For that moment, I felt so insulted and yet I felt so bad. It was my first time having a contact with a "negative" guy."
